HCV D+/R- Kidney Transplantation in the Real-World: Is It Time?
The emergence of direct acting antiviral (DAA) therapy for hepatitis C (HCV) has arguably been one of the most exciting developments in kidney transplantation in the United [...]
Concepcion
Membranous Nephropathy: A Panel Discussion
In a recent Core Curriculum published in AJKD, Loulwa Alsharhan and Laurence H. Beck Jr. discuss the typical features of primary and secondary disease; highlight the target [...]
#NephMadness 2019: Concepcion Chooses Her Champion for Plasma Exchange
Beatrice P. Concepcion @KidneyBea_n Beatrice P. Concepcion is a transplant nephrologist at Vanderbilt University Medical Center in Nashville, Tennessee. In addition to her [...]
Caring for Patients with Hepatitis C and CKD in the Modern Era: The 2018 KDIGO Guideline
Over the last few years, the management of hepatitis C has been revolutionized by the advent of direct antiviral agents (DAA). This has arguably been one of the most [...]
ASERTAA: Towards Optimizing Tacrolimus-based Immunosuppression in African American Kidney Transplant Recipients
Tacrolimus was first discovered by scientists of the Fujisawa Pharmaceutical Company in a soil sample taken from the foot of Mount Tsukuba in Tokyo. Originally called [...]
KDIGO Guidelines on Living Kidney Donors: A Call for A Paradigm Shift
The much-anticipated KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors was recently published. It is available in two versions: a 10-page [...]
The Future of Hepatitis C and Kidney Transplantation
This is Part 2 of a 2-part series on Hepatitis C and kidney transplantation. Part 1 reviewed the history of HCV, the era of IFN therapy, and the use of DAAs in patients with [...]
Hepatitis C and Kidney Transplantation: Past, Present, and Future
This is Part 1 of a 2-part series on Hepatitis C and kidney transplantation, highlighting some of the exciting breakthroughs impacting this field that have come about as a [...]